Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 38% ± 20% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
breast | 100% | 2267.32 | 459 / 459 | 100% | 8.93 | 1114 / 1118 |
bladder | 100% | 3399.62 | 21 / 21 | 100% | 10.13 | 502 / 504 |
lung | 100% | 2939.47 | 577 / 578 | 100% | 10.43 | 1151 / 1155 |
thymus | 100% | 2261.06 | 652 / 653 | 100% | 12.27 | 602 / 605 |
brain | 99% | 4932.23 | 2624 / 2642 | 100% | 15.25 | 704 / 705 |
esophagus | 100% | 2696.81 | 1440 / 1445 | 99% | 10.04 | 182 / 183 |
intestine | 100% | 3352.29 | 966 / 966 | 99% | 5.92 | 522 / 527 |
stomach | 99% | 1793.18 | 355 / 359 | 99% | 6.96 | 283 / 286 |
ovary | 100% | 2140.70 | 180 / 180 | 98% | 6.23 | 420 / 430 |
uterus | 100% | 2663.31 | 170 / 170 | 97% | 7.96 | 447 / 459 |
skin | 99% | 1583.26 | 1797 / 1809 | 98% | 9.72 | 461 / 472 |
adrenal gland | 100% | 2636.58 | 258 / 258 | 96% | 11.15 | 221 / 230 |
prostate | 100% | 2000.36 | 244 / 245 | 96% | 5.94 | 484 / 502 |
kidney | 100% | 1705.89 | 89 / 89 | 95% | 6.88 | 859 / 901 |
pancreas | 89% | 832.08 | 292 / 328 | 99% | 8.13 | 176 / 178 |
liver | 85% | 740.86 | 192 / 226 | 61% | 2.60 | 248 / 406 |
adipose | 100% | 2451.14 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 4407.93 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 8.44 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.69 | 1 / 1 |
blood vessel | 100% | 2320.64 | 1331 / 1335 | 0% | 0 | 0 / 0 |
muscle | 99% | 1349.59 | 795 / 803 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 4085.32 | 918 / 929 | 0% | 0 | 0 / 0 |
heart | 99% | 1624.34 | 850 / 861 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 93% | 8.22 | 27 / 29 |
eye | 0% | 0 | 0 / 0 | 81% | 4.63 | 65 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0007165 | Biological process | signal transduction |
GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
GO_0006661 | Biological process | phosphatidylinositol biosynthetic process |
GO_0043647 | Biological process | inositol phosphate metabolic process |
GO_0031901 | Cellular component | early endosome membrane |
GO_0055038 | Cellular component | recycling endosome membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0031965 | Cellular component | nuclear membrane |
GO_0005886 | Cellular component | plasma membrane |
GO_0014069 | Cellular component | postsynaptic density |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0017161 | Molecular function | inositol-1,3,4-trisphosphate 4-phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0016316 | Molecular function | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity |
GO_0052828 | Molecular function | inositol-3,4-bisphosphate 4-phosphatase activity |
Gene name | INPP4A |
Protein name | Inositol polyphosphate-4-phosphatase type I A (Inositol polyphosphate 4-phosphatase type I) (Type I inositol 3,4-bisphosphate 4-phosphatase) (EC 3.1.3.66) phosphatidylinositol-3,4-bisphosphate 4-phosphatase (EC 3.1.3.66) Inositol polyphosphate-4-phosphatase type I A |
Synonyms | |
Description | FUNCTION: Catalyzes the hydrolysis of the 4-position phosphate of phosphatidylinositol 3,4-bisphosphate (PtdIns(3,4)P2) . Catalyzes also inositol 1,3,4-trisphosphate and inositol 1,4-bisphosphate (By similarity). Antagonizes the PI3K-AKT/PKB signaling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival (By similarity). May protect neurons from excitotoxic cell death by regulating the synaptic localization of cell surface N-methyl-D-aspartate-type glutamate receptors (NMDARs) and NMDAR-mediated excitatory postsynaptic current (By similarity). .; FUNCTION: [Isoform 4]: Displays no 4-phosphatase activity for PtdIns(3,4)P2, Ins(3,4)P2, or Ins(1,3,4)P3. . |
Accessions | ENST00000409016.8 [Q96PE3-2] Q96PE3 ENST00000409540.7 [Q96PE3-4] A0A9L9PY55 ENST00000409463.5 B8ZZB2 ENST00000523221.1 [Q96PE3-1] ENST00000706935.1 ENST00000409851.8 [Q96PE3-3] |